![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
NTRK gene amplification in patients with metastatic cancer |
Su Jin Lee, Nayoung K. D. Kim, Se-Hoon Lee, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Woong Yang Park, Hee Jin Bang, Kyoung-Mee Kim, Keunchil Park, Jeeyun Lee |
Precis Future Med. 2017;1(3):129-137. Published online September 22, 2017 DOI: https://doi.org/10.23838/pfm.2017.00142 |
NTRK gene amplification in patients with metastatic cancer 364P Prevalence, treatment and survival of NTRK gene fusions in microsatellite instable metastatic colorectal cancer patients HER2 Gene Amplification by Fluorescence In Situ Hybridization(FISH) as a Predictor of Response to Trastuzumab in Metastatic Breast Cancer The level of HER2/neu gene amplification as predictive factor in patients with metastatic breast cancer treated with a trastuzumab-based therapy Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability Amplification, mutation and loss of heterozygosity of the EGFR gene in metastatic lung cancer 100P Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice Gene Amplification Methodology matters – prognostic significance of HER2 protein expression versus HER2 gene amplification in metastatic breast cancer 2406 The prognostic impact of FGFR2 gene amplification in patients receiving fiuoropyrimidine and platinum (FP) chemotherapy for with metastatic and locally advanced gastric cancers |